[1,3]Thiazolo[5,4-b]pyridin-2-amine → HCID 11666499, Verbindung
Reaktionsgleichung
C([O:4][C:5]1[CH:6]=[C:7]2[C:12](=[CH:13][CH:14]=1)[N:11]=[CH:10][N:9]=[C:8]2Cl)(=O)C.[N:16]1[C:24]2[C:19](=[N:20][CH:21]=[CH:22][CH:23]=2)[S:18][C:17]=1[NH2:25]>>[OH:4][C:5]1[CH:6]=[C:7]2[C:12](=[CH:13][CH:14]=1)[N:11]=[CH:10][N:9]=[C:8]2[NH:25][C:17]1[S:18][C:19]2[C:24]([N:16]=1)=[CH:23][CH:22]=[CH:21][N:20]=2Komponenten
3
Versuchsvorschrift
The compound of Example 38 was manufactured using 6-acetoxy-4-chloro-quinazoline and thiazolo[5,4-b]pyridin-2-yl-amine by the same method as in Example 1 for the manufacture of 6-iodoquinazolin-4-yl)-thiazolo[5,4-b]pyridin-2-yl-amine, by a similar method thereto or by a combination of such a method with a conventional method.
Quellen und Nachweise
- ORD-Eintrag
- ord-259ff7175f574d4497dc71c4c0b4b6ad
- Quelldatensatz
- uspto-grants-2010_03